Table 4.
Crude 28-day and in-hospital mortality.
| Subgroups | 28-Day Mortality | In-Hospital Mortality | ||
|---|---|---|---|---|
| Treatment | Control | Treatment | Control | |
| Age (years) | ||||
| >75 | 20.7 (12/58) | 17.5 (42/240) | 20.0 (11/58) | 17.9 (43/240) |
| ≤75 | 17.5 (30/171) | 17.5 (118/675) | 15.8 (27/171) | 18.4 (124/675) |
| Renal failure | ||||
| Yes | 29.7 (19/64) | 25.8 (59/229) | 25.0 (16/64) | 26.2 (60/229) |
| No | 13.9 (23/165) | 14.7 (101/686) | 13.3 (22/165) | 15.6 (107/686) |
| Malignancy | ||||
| Yes | 24.1 (22/91) | 23.7 (91/384) | 22.0 (20/91) | 24.0 (92/384) |
| No | 14.5 (20/138) | 13.0 (69/531) | 13.0 (13/138) | 14.1 (75/531) |
| Albumin (mg/dL) | ||||
| ≥3.0 | 13.6 (12/88) | 9.0 (42/465) | 12.5 (11/88) | 9.9 (46/465) |
| <3.0 | 21.3 (30/141) | 26.2 (118/450) | 19.2 (27/141) | 26.9 (121/450) |
| Septic shock criteria | ||||
| Yes | 23.0 (35/152) | 24.7 (109/441) | 21.7 (33/152) | 27.2 (120/441) |
| No | 9.1 (7/77) | 10.8 (51/474) | 6.5 (5/77) | 9.9 (47/474) |
| SOFA score | ||||
| >10 | 30.1 (22/73) | 38.7 (89/230) | 28.8 (21/73) | 42.2 (97/230) |
| ≤10 | 12.8 (20/156) | 10.4 (71/685) | 10.9 (17/156) | 10.2 (70/685) |
| Adjunctive steroid use | ||||
| Yes | 32.3 (20/62) | 30.7 (69/225) | 29.0 (18/62) | 33.3 (75/225) |
| No | 13.2 (22/167) | 13.2 (91/690) | 12.0 (20/167) | 13.3 (92/690) |
Data are shown as % (n). SOFA: Sequential Organ Failure Assessment.